KOSPIChemicals004000

LOTTE Fine Chemical

₩32,250▼ 0.31%2026-11-18 close
Market Cap
₩832B
Turnover
₩800M
Volume
20K
Shares out.
25.8M
PER
4.2×
PBR
0.3×
EPS
₩7,696
Dividend Yield
4.62%

PER, EPS, PBR and BPS are calculated in-house from the last 4 quarters (2025Q4–2026Q3) · Dividend yield is based on ₩1,500 per share · Prices as of the 2026-11-18 close

01

Report overview

LOTTE Fine Chemical: Earnings Recovery Meets Cost Pressure

LOTTE Fine Chemical's operating profit rose 47.6% in 2025 from the prior year, but its operating margin of 4.2% remained well below the 16.4% recorded in 2022, and in the third quarter of 2026 operating profit fell again as chlorine-based raw material costs offset higher TMAC sales.

  1. 1

    Operating profit recovered to KRW 74.4 billion in 2025 from KRW 50.4 billion in 2024, but the 4.2% margin remains far below the 16.4% of 2022.

  2. 2

    Quarterly operating profit climbed to KRW 32.7 billion in the first quarter and KRW 61.9 billion in the second quarter of 2026, then fell to KRW 22 billion in the third quarter.

  3. 3

    Growth drivers are TMAC, a semiconductor process chemical, and clean ammonia, while the main drag is raw material costs in the chlorine-based lineup, including ECH for epoxy resins.

  4. 4

    Samsung Securities said in a report dated November 5, 2026 that it had lowered its target price from KRW 66,000 to KRW 47,000.

  5. 5

    The debt-to-equity ratio was 12.7% at the end of 2025, below 18.1% in 2022, and operating cash flow rose to KRW 300.9 billion from KRW 160 billion in 2024.

02

Business structure

LOTTE Fine Chemical is a chemical company built on chlorine-based, cellulose-based and ammonia-based products, with TMAC, a semiconductor electronic material, added on top.

JobKorea's company profile breaks 2025 sales into chlorine-based products such as ECH, caustic soda and TMAC at 42%, cellulose-based products such as Methocel, Hydroxyethyl cellulose, Anycoat and Anyadd at 29%, ammonia and related items at 27%, and other items at 2%.

Samsung Securities, in a February 2026 report using its own segment classification, put 2025 sales at KRW 638 billion for chlorine, KRW 521 billion for cellulose and KRW 576 billion for ammonia, so the mix differs by source.

In cellulose, the flagship products are Anycoat, a pharmaceutical capsule material, and Anyadd, a food additive, and the company describes itself as the only domestic producer of plant-based specialty cellulose derivatives.

Press reports said cellulose once reached operating margins of up to 20%, making it the most profitable business group. The chlorine group centers on ECH, a raw material for epoxy resins, and caustic soda, so its earnings react sharply to international prices.

According to the same Samsung Securities report, fourth-quarter 2025 segment operating profit was KRW 1.5 billion for chlorine, KRW 7 billion for cellulose and KRW 10.8 billion for ammonia. On the semiconductor side, TMAC production capacity is reported to expand 16% by 2028.

The ammonia business is moving toward wider supply of clean ammonia and bunkering, meaning fuel supply for ships. In short, sales rest on three legacy lines, with semiconductor materials and clean ammonia being added as new growth lines.

03

Earnings trend

Quarterly revenue · Operating profit
RevenueOperating profit
Annual revenue · Operating profit
RevenueOperating profit
Quarterly results · Last 5 quarters
QuarterRevenueOperating profitOp. margin
2025Q3₩443.4B₩27.6B6.2%
2025Q4₩439.1B₩19.3B4.4%
2026Q1₩510.7B₩32.7B6.4%
2026Q2₩586.3B₩61.9B10.6%
2026Q3₩525.3B₩22B4.2%
Annual results
YearRevenueOperating profitNet income (parent)Op. marginROEDebt-to-equity
2022₩2.5T₩404.3B₩146.2B16.4%6.4%18.1%
2023₩1.8T₩154.8B₩182B8.8%7.6%12.6%
2024₩1.7T₩50.4B₩36.4B3.0%1.5%14.6%
2025₩1.8T₩74.4B₩106.1B4.2%4.4%12.7%

Consolidated basis (financial statements including subsidiaries) · Final figures from DART filings · Net income attributable to owners of the parent · Data as of 2026-11-17

04

Earnings analysis

On a disclosed annual basis, sales were KRW 2.46 trillion in 2022, the largest year in the 2022–2025 window, then fell 28.2% to KRW 1.77 trillion in 2023 and 5.5% to KRW 1.67 trillion in 2024, the smallest year, before rising 4.9% to KRW 1.75 trillion in 2025.

Operating profit fell from KRW 404.3 billion in 2022 to KRW 154.8 billion in 2023 (down 61.7%) and KRW 50.4 billion in 2024 (down 67.5%), then recovered to KRW 74.4 billion in 2025 (up 47.6%).

Operating margin moved from 16.4% in 2022 to 8.8% in 2023, 3.0% in 2024 and 4.2% in 2025, so the 2025 margin still sat well below the 2022 level.

Net profit attributable to controlling shareholders was KRW 146.2 billion in 2022, KRW 182 billion in 2023 (up 24.5%), KRW 36.4 billion in 2024 (down 80.0%) and KRW 106.1 billion in 2025 (up 191.6%). Net profit including non-controlling interests matched these figures in each year.

Press coverage described 2025 as a turnaround that broke a stretch of declining results that had run since 2022. Operating cash flow went from KRW 637.9 billion in 2022 to KRW 224.1 billion in 2023 and KRW 160 billion in 2024, then rose to KRW 300.9 billion in 2025.

Quarterly operating profit was KRW 27.6 billion in the third quarter of 2025 and KRW 19.3 billion in the fourth quarter, down 30.0% from the prior quarter, according to the disclosed figures.

Samsung Securities' review showed that fourth-quarter 2025 chlorine segment profit fell to KRW 1.5 billion from KRW 3.5 billion in the third quarter.

The first quarter of 2026 posted sales of KRW 510.7 billion and operating profit of KRW 32.7 billion, up 69.3% from the prior quarter, with reports attributing the gain to higher international chlorine-based product prices and stronger TMAC demand.

Second-quarter 2026 sales were KRW 586.3 billion and operating profit KRW 61.9 billion, up 89.5% from the prior quarter. Third-quarter 2026 sales of KRW 525.3 billion rose 18.5% year on year, while operating profit of KRW 22 billion fell 20.4% year on year.

The company attributed the sales increase to higher ammonia prices and larger TMAC shipments, and the profit decline to higher ECH raw material costs in the chlorine lineup.

Net profit attributable to controlling shareholders totaled KRW 196 billion over the last four quarters, from the fourth quarter of 2025 to the third quarter of 2026.

05

Industry analysis

Chemical industry earnings diverge across business lines depending on end-market demand and raw material prices. The chlorine group carries a heavy cost burden because operating profit shrinks when ECH raw material prices rise.

Cellulose products serve pharmaceutical and food additive uses, and Samsung Securities' November 2026 report cited weak profitability in cellulose industrial products as a factor behind the third-quarter shortfall. The ammonia line benefited from strong international prices that lifted third-quarter sales.

TMAC, a semiconductor process chemical, is reported to have contributed to first-quarter 2026 results as demand rose. Ocean freight costs were also cited as a drag on profitability in some products.

On competitive positioning, the company highlights its domestic production base in cellulose derivatives, while chlorine and ammonia products are more commodity-like and exposed to swings in costs and international prices.

Given the wide quarter-to-quarter swings in operating profit, the business appears to be in a phase where multi-year recovery and quarterly volatility coexist. Some industry observers note that specialty products still do not account for a large enough share to support overall profitability.

Relative positioning versus peers therefore depends on weighing the differentiation of cellulose and semiconductor materials against the cost exposure of the chlorine group.

06

Outlook

The company has said it will raise the share of specialty products by investing in TMAC capacity and expanding its clean ammonia business. Reports say TMAC production capacity is planned to expand 16% by 2028.

The company's website, marking its 60th anniversary, sets a goal of KRW 7 trillion in sales by 2030 as a Global Top 10 specialty company.

Reporting from 2026, however, described a target of KRW 5 trillion in sales by 2030, with KRW 3 trillion from the green materials segment, so the public medium-term figures differ by source.

Samsung Securities said in a report dated November 5, 2026 that it had lowered its target price from KRW 66,000 to KRW 47,000 to reflect weak third-quarter results.

The same report found that third-quarter operating profit fell short of both a market consensus of KRW 33.2 billion and its own estimate of KRW 28.7 billion. It also projected fourth-quarter 2026 operating profit at KRW 13.9 billion.

The reasons cited for the target cut were weaker profitability in ECH and caustic soda, soft cellulose industrial products and ocean freight costs. The next points to watch are how quickly added TMAC volume lifts quarterly sales and how far ECH raw material prices weigh on operating margin.

The next disclosure to check is whether the 2026 annual operating margin in the business report exceeds the 4.2% recorded for 2025.

07

Valuation

PER
4.2×
PBR
0.3×
ROE
7.9%
EPS
₩7,696
BPS
₩100,749
Dividend per share
₩1,500

Valuation is easier to read by separating earnings recovery from the balance sheet than by focusing on the share price alone. The share price sits below book value per share, which is the starting point for interpreting valuation.

All of the KRW 2.44 trillion in total equity at the end of 2025 belongs to controlling shareholders, so the asset base contains no non-controlling interest.

On earnings, net profit attributable to controlling shareholders rose to KRW 106.1 billion in 2025 from KRW 36.4 billion in 2024, and totaled KRW 196 billion over the last four quarters.

Because quarterly profit swings widely, earnings-based multiples move with the quarterly trend and should be read alongside the earnings trajectory rather than a single point in time. Samsung Securities also listed a lower price-to-book assumption in its target price calculation as one reason for the cut. The debt-to-equity ratio fell to 12.7% in 2025 from 18.1% in 2022, which points to a lighter financial burden.

PER, EPS, PBR and BPS are all calculated in-house (the same method as Naver and Toss) · Dividend yield = cash dividend per share from DART filings (supplemented by KRX) ÷ current price · As of 2026-11-17

08

Bull factors

TMAC as a growth line

TMAC, a semiconductor process chemical, has been cited as a main driver of sales growth in the first and third quarters of 2026. Reports say its production capacity is planned to expand 16% by 2028. The company presents the TMAC expansion as a future growth engine.

Signs of earnings recovery

Operating profit rose 47.6% in 2025, and net profit attributable to controlling shareholders rose 191.6%. Second-quarter 2026 operating profit of KRW 61.9 billion was the highest of the last five quarters. Net profit attributable to controlling shareholders totaled KRW 196 billion over the last four quarters.

Financial room and cash generation

The debt-to-equity ratio was 12.7% at the end of 2025, down from 18.1% in 2022. Operating cash flow rose to KRW 300.9 billion in 2025 from KRW 160 billion in 2024. Total liabilities stood at KRW 310.4 billion, a modest burden relative to equity.

09

Bear factors

Quarterly swings from raw material costs

Third-quarter operating profit of KRW 22 billion fell 64.5% from the prior quarter. The company attributed the decline mainly to higher raw material prices in the chlorine lineup, including ECH. Sales rose over the same period but did not offset the cost burden.

A thin operating margin

The operating margin was 4.2% in 2025, far below 16.4% in 2022. It fell to 8.8% in 2023 and 3.0% in 2024 before the 2025 partial recovery. The margin still remains below the 2022 level.

Target price cut and a consensus miss

Samsung Securities said in a report dated November 5, 2026 that third-quarter operating profit fell below a market consensus of KRW 33.2 billion. The cited factors included weaker ECH and caustic soda profitability and ocean freight costs.

10

Risk factors

Raw material and international price risk

When ECH and other chlorine-lineup raw material prices rise, operating profit can shrink quickly. International ammonia prices are also a key variable for sales. If the two move in opposite directions, quarterly results can swing sharply.

Medium-term targets and execution of expansions

The 2030 sales target is reported differently across sources, as KRW 7 trillion and KRW 5 trillion. The timing and pace of returns from the TMAC expansion and clean ammonia projects remain uncertain. Any delay would push back the goal of raising the specialty share.

Concentration in semiconductor material demand

Because TMAC sales have become a central driver of growth, the company is exposed to swings in semiconductor cycles. A structure that leans on one product's demand feeds directly into earnings when demand slows. Some industry observers note that specialty products are not yet large enough to carry overall profitability.

11

What to watch next

  1. Early February 2027

    This is the usual window for the provisional fourth-quarter 2026 results. The check is whether operating profit recovered from the KRW 22 billion of the third quarter and whether ECH cost pressure persisted.

  2. Late March 2027

    This is the filing deadline for the 2026 annual business report, the next periodic filing. Key checks are whether the annual operating margin exceeds 4.2% and how the segment sales mix shifted.

  3. Around late April 2027

    This is the usual timing for first-quarter 2027 results. The check is whether added TMAC volume and international ammonia prices keep supporting sales, and whether chlorine-lineup costs stabilize.

  4. 2028

    This is the target year for the planned 16% expansion of TMAC production capacity. Whether the expansion stays on schedule and how much semiconductor materials grow in the sales mix will indicate execution over the medium term.

12

Overall view

LOTTE Fine Chemical's recent results show recovery alongside volatility. Operating profit rose 47.6% to KRW 74.4 billion in 2025, and net profit attributable to controlling shareholders rose 191.6% to KRW 106.1 billion. Even so, the 4.2% operating margin in 2025 remains far below the 16.4% of 2022.

Operating profit climbed to KRW 32.7 billion in the first quarter and KRW 61.9 billion in the second quarter of 2026, then fell to KRW 22 billion in the third quarter. The growth driver of TMAC and clean ammonia and the cost drag from the chlorine lineup are operating at the same time.

Samsung Securities said in a November 5, 2026 report that it had lowered its target price to KRW 47,000, and the 2030 sales target is described differently across sources. The debt-to-equity ratio of 12.7% is lower than in 2022.

The next checkpoints are the annual operating margin in the 2026 business report and the trend in TMAC volume and ECH costs after the first quarter of 2027.

13

Sources

  1. Korea Exchange (KRX) — Prices · Market Cap · Volume
  2. FSS electronic disclosure system (DART) — Financial statements · Dividend filings
Show 16 more articles and sources
  1. jobkorea.co.kr
  2. econovill.com
  3. catch.co.kr
  4. dealsite.co.kr
  5. econovill.com
  6. lottefinechem.com
  7. bloter.net
  8. samsungpop.com
  9. straightnews.co.kr
  10. vegannews.co.kr
  11. dailian.co.kr
  12. kbthink.com
  13. newsworks.co.kr
  14. businesspost.co.kr
  15. cbci.co.kr
  16. vegannews.co.kr

Report written 2026-11-18 · Data as of 2026-11-17

This content is AI analysis of market data and web search results, provided for information only. It is not a solicitation or recommendation to invest. Investment decisions and their consequences are the investor's own responsibility. Data may be delayed or contain errors.

Other reports in this industry

View industry analysis